Rhode Island Hospital-Lifespan Cancer Institute — Providence, Rhode Island

Rhode Island Hospital-Lifespan Cancer Institute is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Rhode Island Hospital-Lifespan Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Providence

Browse all research sites in Rhode Island · View every site in Providence

• The Miriam Hospital Clinical Research Site (TMH CRS) CRS
• Brown University Oncology Research Group
• Women & Infants Hospital /ID# 269032
• Rhode Island Hospital /ID# 151538
• VA Providence Healthcare System
• Hasbro Children's Hospital/Rhode Island Hospital
• Brown University Health - Lipid Clinic
• Lifespan Cancer Institute at Rhode Island Hospital
• Department of Orthopaedic Surgery, Rhode Island Hospital
• Vascular Disease Research Center at Rhode Island Hospital
• RI Hospital
• The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital-Lifespan Cancer Institute?

Rhode Island Hospital-Lifespan Cancer Institute has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital-Lifespan Cancer Institute conducted?

Rhode Island Hospital-Lifespan Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.

Is Rhode Island Hospital-Lifespan Cancer Institute accredited by Crixeo Clinical Trials?

Rhode Island Hospital-Lifespan Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital-Lifespan Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.